Skip to main content

CASE REPORT article

Front. Pediatr.

Sec. Pediatric Infectious Diseases

Volume 13 - 2025 | doi: 10.3389/fped.2025.1567164

Post-Varicella Vaccination Uveitis in a Child with Nephrotic Syndrome receiving Immunosuppressive Treatment: A Case Report

Provisionally accepted
Catarina Jardim Andrade Catarina Jardim Andrade 1,2Miguel Cordeiro Miguel Cordeiro 3Rute Baptista Rute Baptista 4,5,6Beatriz Sousa Nunes Beatriz Sousa Nunes 6,7Ana Margarida Garcia Ana Margarida Garcia 1,6Tiago Milheiro Silva Tiago Milheiro Silva 1,6Marta Valente Pinto Marta Valente Pinto 6,8,9*
  • 1 Infectious Diseases Unit, Unidade Local de Saúde São José, Hospital de Dona Estefânia, Lisbon, Portugal
  • 2 Pediatrics, Hospital Central do Funchal, SESARAM, EPERAM, Funchal, Portugal
  • 3 Ophthalmology Department, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, Portugal
  • 4 Paediatric Nephrology Unit, Unidade Local de Saúde São José, Hospital de Dona Estefânia, Lisbon, Portugal
  • 5 Faculty of Medicine, NOVA University of Lisbon, Lisbon, Lisboa, Portugal
  • 6 Centro Clínico Académico de Lisboa, Lisboa, Portugal
  • 7 Infectious Diseases Unit, Hospital de Dona Estefânia, Lisbon, Portugal
  • 8 Primary Immunodeficiency Unit, Unidade Local de Saúde São José, Hospital de Dona Estefânia, Lisbon, Portugal
  • 9 Egas Moniz Center for Interdisciplinary Research (CiiEM), Almada, Setúbal, Portugal

The final, formatted version of the article will be published soon.

    Patients with nephrotic syndrome are at heightened risk of infections due to the underlying disease pathophysiology and the effects of immunosuppressive therapies. Varicella-zoster virus (VZV) infection can cause severe complications in immunocompromised individuals. Concerns about the safety of live attenuated vaccines in this population persist. Emerging vaccination strategies incorporate pre-vaccination risk stratification algorithms based on immunological criteria. We present a case of a five-year-old male with corticosteroid-dependent nephrotic syndrome, in complete remission on mycophenolate mofetil therapy, who received the varicella vaccine after meeting immunocompetence criteria. Fourteen days post-vaccination, he developed scant vesicular lesions, with VZV DNA detected by PCR via swab. By day 16 post-vaccination, he presented with left-eye panuveitis. VZV DNA was also detected in the blood by PCR. Differentiation of VZV vaccine strains from wild-type strains was not possible. Additionally, molecular testing for VZV in the aqueous humor was not performed. However, given the temporal association with varicella vaccination, the detection of VZV in the blood and cutaneous lesions, and most importantly, the immunosuppression of the patient, post-vaccination ocular varicella was assumed even without an epidemiological history of varicella exposure. This case highlights the importance of a thorough immunocompetence assessment before administering live vaccines to immunosuppressed patients, as well as close post-vaccine monitoring and a high index of suspicion for complications to optimize vaccine safety in this vulnerable group. Patients with nephrotic syndrome require vaccination strategies tailored to their individual risk.

    Keywords: Attenuated vaccine, Immunocompromised patient, Nephrotic Syndrome, Uveitis, Varicella vaccine

    Received: 26 Jan 2025; Accepted: 28 Mar 2025.

    Copyright: © 2025 Jardim Andrade, Cordeiro, Baptista, Sousa Nunes, Garcia, Silva and Valente Pinto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Marta Valente Pinto, Primary Immunodeficiency Unit, Unidade Local de Saúde São José, Hospital de Dona Estefânia, Lisbon, Portugal

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more